PALM BEACH, FLA. – The Dana-Farber Cancer Institute is thrilled to welcome its new President and CEO, Dr. Benjamin Ebert, who will spearhead discussions with an esteemed panel of faculty members. This year’s annual Breakfast with the Doctors event promises to spotlight the latest breakthroughs and pivotal advancements in cancer research and patient care. Scheduled for Tuesday, March 4 from 9 to 11 a.m. at The Beach Club in Palm Beach, the event will be chaired and generously underwritten by the prominent Schlager Weinstein families, with additional sponsorship from member Frank Chopin.
In addition to Dana-Farber CEO Dr. Benjamin L. Ebert, MD, PhD, the panel will feature other illustrious figures in cancer treatment and research. George P. Canellos, MD, and Jean S. Canellos Professor of Medicine at Harvard Medical School, will also share his insights alongside a renowned lineup of Dana-Farber faculty.
Toni Choueiri, MD, who serves as the Director of the Lank Center for Genitourinary Oncology and Medical Director for International Strategic Initiatives at Dana-Farber, will discuss cutting-edge treatment strategies as well as research in the field.
Cigall Kadoch, PhD, a key Principal Investigator in Pediatric Oncology, will present her groundbreaking research and its impacts on pediatric cancer care.
Ann Partridge, MD, MPH, who is the Interim Chair of Medical Oncology, will highlight her work as the Founder and Director of the Program for Young Adults with Breast Cancer, along with overseeing the Adult Survivorship Program, aiming to guide young patients through their cancer journeys.
Eric P. Winer, MD, who holds the Chair in Breast Cancer Research, will contribute his extensive expertise in developing new treatment modalities for breast cancer patients.
Catherine Wu, MD, the Chief of the Division of Stem Cell Transplantation and Cellular Therapies, will discuss advances in preventative cancer therapies, sharing critical insights from her role as the Lavine Family Chair for these vital cancer strategies.
For decades, the tight-knit Palm Beach community has shown remarkable support for Dana-Farber’s researchers, caregivers, and patients, continuously advancing the institute’s lifesaving mission of defying cancer, not just in Boston, but across the nation and beyond. For those interested in attending Breakfast with the Doctors, please reach out to Karen Martins at [email protected] or by calling 561-833-2080 for further details.
About Dana-Farber Cancer Institute
Dana-Farber Cancer Institute stands as one of the world’s premier centers dedicated to cancer research and treatment. The institute’s mission focuses on reducing the burden of cancer through rigorous scientific inquiry, top-notch clinical care, educational programs, community engagement initiatives, and robust advocacy efforts. Recognized as a federally designated Comprehensive Cancer Center and a teaching affiliate of Harvard Medical School, Dana-Farber excels in delivering the latest treatments for adult patients through Dana-Farber Brigham Cancer Center and for pediatric patients through the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Impressively, Dana-Farber is the only hospital in the nation that holds a top 4 ranking in the U.S. News & World Report’s Best Cancer Hospitals for both adult and pediatric care. As a global leader in oncology, Dana-Farber is committed to maintaining a unique and equitable balance between pioneering cancer research and comprehensive patient care, converting groundbreaking discoveries into innovative treatments. The institute currently offers more than 1,100 clinical trials to enhance patient outcomes.
###
**Interview with Dr. Benjamin Ebert, New President and CEO of Dana-Farber Cancer Institute**
**Interviewer:** Good morning, Dr. Ebert, and welcome! Congratulations on your new role as President and CEO of Dana-Farber Cancer Institute. Can you share what this position means to you personally and professionally?
**Dr. Benjamin Ebert:** Thank you! It’s an honor to lead such a prestigious institution dedicated to cancer research and patient care. Personally, it’s fulfilling to be in a position where I can influence the future of cancer treatment and enhance patient experiences. Professionally, it’s a unique opportunity to work alongside some of the brightest minds in oncology.
**Interviewer:** This year’s “Breakfast with the Doctors” event sounds exciting, as it will highlight breakthroughs in cancer research. What can attendees expect from your panel of distinguished faculty members?
**Dr. Ebert:** Attendees can look forward to an engaging discussion around the latest advancements in cancer research and treatment strategies. We have an incredible panel featuring renowned experts, each of whom will present on cutting-edge research, emerging therapies, and how these can improve patient outcomes.
**Interviewer:** You’ll be joined by quite a few distinguished guests, including Dr. Toni Choueiri and Dr. Cigall Kadoch. Can you tell us more about the significance of their contributions?
**Dr. Ebert:** Absolutely! Dr. Choueiri’s work in genitourinary oncology is particularly relevant as we explore innovative treatment approaches. Dr. Kadoch’s research in pediatric oncology is groundbreaking and critical for advancing care for our youngest patients. Their insights will surely inspire and inform our guests.
**Interviewer:** The Palm Beach community has a rich history of supporting Dana-Farber. How do you see this event strengthening those ties?
**Dr. Ebert:** Community support is vital in our fight against cancer. “Breakfast with the Doctors” not only brings together our leading researchers with the community but also fosters deeper connections with supporters who are passionate about improving cancer care. It’s a wonderful opportunity for shared learning and collaboration.
**Interviewer:** What message do you want to leave with attendees at this event?
**Dr. Ebert:** I want them to know that their support is making a difference. Together with the remarkable team at Dana-Farber, we’re committed to transforming the landscape of cancer treatment and research. Our mission is to improve lives and eventually, to find a cure.
**Interviewer:** Thank you so much for your time, Dr. Ebert. We look forward to hearing from you and the entire panel at the event on March 4!
**Dr. Ebert:** Thank you! I’m looking forward to it as well.
